Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Bispecific Antibodies for Cancer market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bispecific Antibodies for Cancermarket, defines the market attractiveness level of Bispecific Antibodies for Cancer market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bispecific Antibodies for Cancer industry, describes the types of Bispecific Antibodies for Cancer market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bispecific Antibodies for Cancer market and the development prospects and opportunities of Bispecific Antibodies for Cancer industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bispecific Antibodies for Cancer market in Chapter 13.
By Player:
Amgen
Astella Pharma
Regeneron Pharmaceuticals
Ben Kang Biopharmaceutical (Shenzhen)
Merus
By Type:
CD19/CD3
CD30/CD16A
By End-User:
Hospital
Pharmaceutical Companies
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bispecific Antibodies for Cancer Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bispecific Antibodies for Cancer Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bispecific Antibodies for Cancer Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bispecific Antibodies for Cancer Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bispecific Antibodies for Cancer Market Analysis and Outlook to 2022
-
7.1 Global Bispecific Antibodies for Cancer Consumption (2017-2022)
-
7.2 United States Bispecific Antibodies for Cancer Consumption (2017-2022)
-
7.3 Europe Bispecific Antibodies for Cancer Consumption (2017-2022)
-
7.4 China Bispecific Antibodies for Cancer Consumption (2017-2022)
-
7.5 Japan Bispecific Antibodies for Cancer Consumption (2017-2022)
-
7.6 India Bispecific Antibodies for Cancer Consumption (2017-2022)
-
7.7 South Korea Bispecific Antibodies for Cancer Consumption (2017-2022)
8 Region and Country-wise Bispecific Antibodies for Cancer Market Analysis and Outlook to 2028
-
8.1 Global Bispecific Antibodies for Cancer Consumption Forecast (2022-2028)
-
8.2 United States Bispecific Antibodies for Cancer Consumption Forecast (2022-2028)
-
8.3 Europe Bispecific Antibodies for Cancer Consumption Forecast (2022-2028)
-
8.4 China Bispecific Antibodies for Cancer Consumption Forecast (2022-2028)
-
8.5 Japan Bispecific Antibodies for Cancer Consumption Forecast (2022-2028)
-
8.6 India Bispecific Antibodies for Cancer Consumption Forecast (2022-2028)
-
8.7 South Korea Bispecific Antibodies for Cancer Consumption Forecast (2022-2028)
9 Global Bispecific Antibodies for Cancer Market Outlook by Types and Applications to 2022
-
9.1 Global Bispecific Antibodies for Cancer Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global CD19/CD3 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global CD30/CD16A Consumption and Growth Rate (2017-2022)
-
9.2 Global Bispecific Antibodies for Cancer Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Bispecific Antibodies for Cancer Market Outlook by Types and Applications to 2028
-
10.1 Global Bispecific Antibodies for Cancer Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global CD19/CD3 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global CD30/CD16A Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bispecific Antibodies for Cancer Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Bispecific Antibodies for Cancer Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bispecific Antibodies for Cancer Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bispecific Antibodies for Cancer Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bispecific Antibodies for Cancer Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bispecific Antibodies for Cancer Market Competitive Analysis
-
14.1 Amgen
-
14.1.1 Amgen Company Details
-
14.1.2 Amgen Bispecific Antibodies for Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Amgen Bispecific Antibodies for Cancer Product and Service
-
14.2 Astella Pharma
-
14.2.1 Astella Pharma Company Details
-
14.2.2 Astella Pharma Bispecific Antibodies for Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Astella Pharma Bispecific Antibodies for Cancer Product and Service
-
14.3 Regeneron Pharmaceuticals
-
14.3.1 Regeneron Pharmaceuticals Company Details
-
14.3.2 Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Product and Service
-
14.4 Ben Kang Biopharmaceutical (Shenzhen)
-
14.4.1 Ben Kang Biopharmaceutical (Shenzhen) Company Details
-
14.4.2 Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Product and Service
-
14.5 Merus
-
14.5.1 Merus Company Details
-
14.5.2 Merus Bispecific Antibodies for Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merus Bispecific Antibodies for Cancer Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bispecific Antibodies for Cancer
-
Figure Bispecific Antibodies for Cancer Picture
-
Table Global Bispecific Antibodies for Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bispecific Antibodies for Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bispecific Antibodies for Cancer Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bispecific Antibodies for Cancer Consumption by Country (2017-2022)
-
Figure United States Bispecific Antibodies for Cancer Consumption and Growth Rate (2017-2022)
-
Table Europe Bispecific Antibodies for Cancer Consumption and Growth Rate (2017-2022)
-
Figure China Bispecific Antibodies for Cancer Consumption and Growth Rate (2017-2022)
-
Figure Japan Bispecific Antibodies for Cancer Consumption and Growth Rate (2017-2022)
-
Figure India Bispecific Antibodies for Cancer Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bispecific Antibodies for Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Bispecific Antibodies for Cancer Consumption Forecast by Country (2022-2028)
-
Figure United States Bispecific Antibodies for Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bispecific Antibodies for Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bispecific Antibodies for Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bispecific Antibodies for Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bispecific Antibodies for Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bispecific Antibodies for Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CD19/CD3 Consumption and Growth Rate (2017-2022)
-
Figure Global CD30/CD16A Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global CD19/CD3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CD30/CD16A Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bispecific Antibodies for Cancer Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bispecific Antibodies for Cancer Export by Region (Top 5 Countries) (2017-2028)
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Bispecific Antibodies for Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Bispecific Antibodies for Cancer Product and Service
-
Table Astella Pharma (Foundation Year, Company Profile and etc.)
-
Table Astella Pharma Bispecific Antibodies for Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astella Pharma Bispecific Antibodies for Cancer Product and Service
-
Table Regeneron Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Product and Service
-
Table Ben Kang Biopharmaceutical (Shenzhen) (Foundation Year, Company Profile and etc.)
-
Table Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Product and Service
-
Table Merus (Foundation Year, Company Profile and etc.)
-
Table Merus Bispecific Antibodies for Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merus Bispecific Antibodies for Cancer Product and Service
-
